Skip to main content
Log in

Protein binding of the analgesics alfentanil and sufentanil in maternal and neonatal plasma

  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Maternal and umbilical venous plasma was obtained at delivery from 8 mothers and their neonates after an i.v. bolus injection of alfentanil, and from 6 mothers and their neonates after epidural administration of sufentanil. Plasma levels of total (free + bound) alfentanil in neonates were about 3.4-times lower than in their mothers. At 33–55 min after 30 µg sufentanil, total drug levels in mothers were around the limit of detection of the radioimmunoassay (0.05 ng/ml); in one mother who had received 250 µg, the plasma level of total sufentanil was 2.6-times higher than in her neonate. Plasma protein binding of alfentanil was 88.2% in mothers and 67.2% in neonates. Plasma protein binding of sufentanil was 90.7% in mothers and 79.3% in neonates. For both drugs, plasma protein binding was significantly related to the α1-acid glycoprotein (α1-AGP) level, which was about 2.5-times lower in the infants. Free alfentanil levels in mothers and neonates were similar. Free levels of sufentanil in mothers and neonates differed less from each other than did the total drug levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mather L (1983) Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 8: 422–446

    Google Scholar 

  2. Hull CJ (1983) The pharmacokinetics of alfentanil in man. Br J Anaesth 5: 157S-164S

    Google Scholar 

  3. Hug CC, Chaffman M (1984) Alfentanil: Pharmacology and uses in anaesthesia. ADIS Press, Auckland New Zealand, Chapter I

    Google Scholar 

  4. Stanski DR, Hug CC (1982) Alfentanil — a kinetically predictable narcotic analgesic. J Anaesthesiol 57: 435–438

    Google Scholar 

  5. Bovill JG, Sebel PS, Blackburn CL, Oei-Lim V, Heykants JJ (1984) The pharmacokinetics of sufentanil in surgical patients. Anaesthesiology 61: 502–506

    Google Scholar 

  6. Meuldermans W, Hurkmans R, Heykants J (1982) Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood. Arch Int Pharmacodyn Ther 257: 4–19

    Google Scholar 

  7. Paxton J (1983) Alpha1-acid glycoprotein and binding of basic drugs. Methods Find Exp Clin Pharmacol 5: 635–648

    Google Scholar 

  8. Michiels M, Hendriks R, Heykants J (1983) Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Pharmacokinetic profile in man. J Pharm Pharmacol 35: 86–93

    Google Scholar 

  9. Song C, Merkatz I, Rifkind A, Gillette P, Kappas A (1970) The influence of pregnancy and oral contraceptives on the concentration of plasma proteins. Am J Obstet Gynecol 108: 227–231

    Google Scholar 

  10. Gleichman W, Bachmann G, Dengler H, Dudeck J (1973) Effects of hormonal contraceptives and pregnancy on serum protein patterns. Eur J Clin Pharmacol 5: 218–226

    Google Scholar 

  11. Wood M, Wood A (1981) Changes in plasma drug binding and α1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 29: 522–526

    Google Scholar 

  12. Denson D, Coyle D, Thompson G, Santos D, Turner P, Myers J, Knapp R (1984) Bupivacaine protein binding in the term parturient: Effects of lactic acidosis. Clin Pharmacol Ther 35: 72–709

    Google Scholar 

  13. Müller W, Stillbauer A (1983) Characterization of a common binding site for basic drugs on human α1-acid glycoprotein (orosomucoid). Naunyn-Schmiedeberg's Arch Pharmacol 322: 170–173

    Google Scholar 

  14. Sann L, Bienvenu J, Lahet C, Divry P, Cotte J, Bethenod M (1981) Serum orosomucoid concentration in newborn infants. Eur J Pediatr 136: 181–185

    Google Scholar 

  15. Philip A, Hewitt J (1983) α1-Acid glycoprotein in the neonate with and without infection. Biol Neonate 43: 118–124

    Google Scholar 

  16. Krauer B, Dayer P, Anner R (1984) Changes in serum albumin and α1-acid glycoprotein concentrations during pregnancy: An analysis of fetal-maternal pairs. Br J Obstet Gynaecol 91: 875–881

    Google Scholar 

  17. Nation R (1981) Meperidine binding in maternal and fetal plasma. Clin Pharmacol Ther 29: 472–479

    Google Scholar 

  18. Herngren L, Ehrnebo M, Boréus L (1983) Drug binding to plasma proteins during human pregnancy and in the perinatal period. Studies on cloxacillin and alprenolol. Dev Pharmacol Ther 6: 110–124

    Google Scholar 

  19. Petersen M, Moore R, Nation R, McMeniman W (1981) Relationship between the transplacental gradients of bupivacaine and α1-acid glycoprotein. Br J Clin Pharmacol 12: 859–862

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meuldermans, W., Woestenborghs, R., Noorduin, H. et al. Protein binding of the analgesics alfentanil and sufentanil in maternal and neonatal plasma. Eur J Clin Pharmacol 30, 217–219 (1986). https://doi.org/10.1007/BF00614307

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00614307

Key words

Navigation